We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
(+82%)
Cap. Flow
+$2.4B
Cap. Flow
% of AUM
40.37%
Top 10 Holdings %
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$179M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Tesla
TSLA
|
+$84M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$59.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$685M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$54.5M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$42.1M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$27.7M |
| 5 |
iShares Russell 1000 ETF
IWB
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.76% |
| 2 | Financials | 11.47% |
| 3 | Healthcare | 11.18% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Nektar Therapeutics
NKTR
$2.57B
| $196K | ﹤0.01% |
653
-372
| -36% | -$116K |
|
2027
Sprouts Farmers Market
SFM
$7.83B
| $196K | ﹤0.01% |
7,380
-15,739
| -68% | -$358K |
|
|
UCB
2028
United Community Banks
UCB
$4.37B
| $196K | ﹤0.01% |
5,741
-1,666
| -22% | -$54.7K |
|
2029
WisdomTree US AI Enhanced Value Fund
AIVL
$434M
| $195K | ﹤0.01% |
2,070
-2,975
| -59% | -$264K |
|
2030
Euronet Worldwide
EEFT
$2.61B
| $195K | ﹤0.01% |
1,411
-935
| -40% | -$135K |
|
2031
The GEO Group
GEO
$4.08B
| $195K | ﹤0.01% |
25,228
+19,699
| +356% | +$162K |
|
|
TBHC
2032
DELISTED
The Brand House Collective
TBHC
| $195K | ﹤0.01% |
6,938
+3,133
| +82% | +$78.2K |
|
2033
Royalty Pharma
RPRX
$26.2B
| $195K | ﹤0.01% |
4,471
+2,414
| +117% | +$114K |
|
|
LGF.B
2034
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $195K | ﹤0.01% |
15,116
+11,681
| +340% | +$154K |
|
|
VIVO
2035
DELISTED
Meridian Bioscience Inc
VIVO
| $195K | ﹤0.01% |
7,402
+4,052
| +121% | +$96.3K |
|
2036
Tompkins Financial
TMP
$1.44B
| $193K | ﹤0.01% |
2,342
+442
| +23% | +$34.8K |
|
|
FABC
2037
Fabric.AI Inc
FABC
$19M
| $192K | ﹤0.01% |
231
+194
| +524% | +$177K |
|
2038
First Financial Bancorp
FFBC
$3.58B
| $192K | ﹤0.01% |
7,999
+661
| +9% | +$14.6K |
|
2039
Lufax Holding
LU
$1.31B
| $192K | ﹤0.01% |
3,307
-4,526
| -58% | -$278K |
|
2040
Roblox
RBLX
$25.2B
| $192K | ﹤0.01% |
+2,967
| New | +$207K |
|
2041
ProShares UltraPro Short MidCap400
SMDD
$1.9M
| $192K | ﹤0.01% |
3,049
+6
| +0.2% | +$454 |
|
2042
United Natural Foods
UNFI
$2.91B
| $192K | ﹤0.01% |
5,816
+1,811
| +45% | +$50.4K |
|
|
PTRA
2043
DELISTED
Proterra Inc. Common Stock
PTRA
| $192K | ﹤0.01% |
+10,754
| New | +$223K |
|
2044
First Majestic Silver
AG
$9.44B
| $191K | ﹤0.01% |
12,272
-25,482
| -67% | -$409K |
|
2045
HNI Corp
HNI
$3.53B
| $191K | ﹤0.01% |
4,817
+902
| +23% | +$33.1K |
|
|
CXP
2046
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $191K | ﹤0.01% |
11,199
+5,675
| +103% | +$83.9K |
|
2047
Invesco S&P SmallCap Materials ETF
PSCM
$21.7M
| $190K | ﹤0.01% |
+3,017
| New | +$189K |
|
2048
Solid Biosciences
SLDB
$976M
| $190K | ﹤0.01% |
2,298
+2,005
| +684% | +$222K |
|
2049
Virtus Investment Partners
VRTS
$1.11B
| $190K | ﹤0.01% |
804
+411
| +105% | +$98.9K |
|
|
HTLF
2050
DELISTED
Heartland Financial USA, Inc.
HTLF
| $190K | ﹤0.01% |
3,781
+1,057
| +39% | +$49.7K |
|
Similar funds
CA
BHC
ICP
AP
BWA
JSW
SP
GCM
Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review
As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.
- Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
- Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
- Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
- Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
- Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
- Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
- Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.